Celgene is set for an exit having invested $17m in small molecule cancer drug developer Nurix Therapeutics five years ago.

Novo and Sanofi are among the investors that could exit the mineralisation disease therapy developer, which has filed to raise up to $86.3m.

Accenture Ventures founder Michael Redding is leaving its parent company – consulting firm Accenture – after almost 30 years.

Colin Steen, one of Syngenta Ventures' managing directors, has departed from the unit after more than two years for a chief executive role elsewhere.

The American Express, Comcast and Amazon-backed shopping service is valued at $13.8bn having raised $100m from T.Rowe Price for its latest round.

ACVC Partners and Motus Ventures have received commitments from the car components manufacturer that jointly total $20m.

The mother-focused recruitment platform developer increased its total funding to about $36m in a round that included new investors Citi and Synchrony.

Existing backer GV helped the data storage technology provider hike its overall funding to more than $56m as it appoints a new chief executive.

The secure crypto wallet provider has secured CommerzVentures, Coinbase Ventures and Digital Garage Lab Fund as investors in its latest round.

The genetic testing services provider has added a Samsung-led second close to a $23m first tranche that included a range of corporate investors.